Rabbit Polyclonal LDL Receptor antibody. Suitable for IP and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Synthetic Peptide within Human Low-density lipoprotein receptor aa 800-900.
View Alternative Names
Low-density lipoprotein receptor, LDL receptor, LDLR
- IP
Supplier Data
Immunoprecipitation - Anti-LDL Receptor antibody (AB240748)
LDL Receptor was immunoprecipitated from HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate (1 mg for IP, 20% of IP loaded) with ab240748 at 6 μg/reaction. Western blot was performed from the immunoprecipitate using ab240748 at 1 μg/ml.
Lane 1 : ab240748 IP in HeLa whole cell lysate.
Lane 2 : Control IgG IP in HeLa whole cell lysate.
Detection : Chemiluminescence with exposure time of 3 minutes.
Lysate prepared using NETN buffer.
All lanes:
Immunoprecipitation - Anti-LDL Receptor antibody (ab240748)
Predicted band size: 95 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The LDL receptor interacts with LDL particles to regulate cholesterol levels in the body. It is part of a cell surface complex that recognizes and binds to apolipoprotein B-100 or apolipoprotein E present on LDL. This interaction initiates internalization of LDL leading to its degradation in lysosomes where cholesterol can be released and used by the cell. Mutations in the gene encoding LDLR can lead to inefficient cholesterol uptake influencing various metabolic processes.
Pathways
LDL receptor activities are integral to lipid metabolism and cholesterol homeostasis. Two important biological pathways that involve LDLR include the cholesterol biosynthesis pathway and the lipoprotein clearance pathway. Within these pathways LDLR collaborates closely with proteins like PCSK9 which modulates its expression and degradation and HMG-CoA reductase an important enzyme in cholesterol synthesis to balance cholesterol levels in the body.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
BMC developmental biology 20:22 PubMed33203369
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com